Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment
The application was based on data from a late-stage trial in which TEV-'749 administered as a once-monthly subcutaneous injection demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations.
Stocktwits·5d ago
More News
Polestar Announces $200M Funding From Geely Chairman’s PSD Investments: Retail Sees Profitability ‘Very Soon’
Polestar has agreed to sell over 190 million newly issued American Depositary Shares to PSD Investment for an aggregate price of $200 million.
Stocktwits·8mo ago
Polestar To Resume Expansion Into New Markets With France, Says Report: Retail’s Still Skeptical
The first showroom in France is expected to open in Le Mans in July, with the initial deliveries slated for October, according to a Reuters report.
Stocktwits·9mo ago
Grab Cools Off Merger Talks With GoTo, Says Report: Retail Keeps Faith
Grab has reportedly indicated a pause or potential halt in its merger talks with GoTo amid regulatory concerns and political backlash in Indonesia over concerns about competition and consumer impact.
Stocktwits·9mo ago
Is WisdomTree International Equity ETF (DWM) a Strong ETF Right Now?
Zacks·9mo ago
Shopee Parent Sea Ltd Swings To Profit On Strong E-commerce Growth; Retail Investors Excited
Shares climbed 8% to their highest level since November 2021.
The Swedish company reported retail sales amounting to an estimated 12,304 units, driven by a growing uptake of newer models and transition to an active selling model.
Stocktwits·11mo ago
ZIM Stock Rises After Signing Long-Term Charters For LNG Container Vessels, Retail Stays Bearish
The vessels will be built in the Zhoushan Changhong Shipyard in China. Delivery is expected between 2027 and 2028.